Skip to main content
John Kirkwood, MD, Oncology, Pittsburgh, PA

John Munn Kirkwood MD

Melanoma


Distinguished Professor of Medicine, Dermatology & Translational Science; Usher Endowed Professor of Medicine, University of Pittsburgh School of Medicine; Co-Director Melanoma and Skin Cancer Program, UPMC Hillman Cancer Institute

Join to view full profile
  • 5150 Centre Ave# CancerPittsburgh, PA 15232

  • Phone+1 412-692-4724

Dr. Kirkwood is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • John Kirkwood, MD, is an internationally respected medical oncologist based in Pittsburgh, PA, with a focus upon melanoma. His education includes residency in Internal Medicine at Yale and Fellowship in Medical Oncology at Harvard Dana-Farber Cancer Institute. Since 1986, he has been Director of the Melanoma and Skin Cancer Program at UPMC Hillman he is Distinguished Professor of Medicine, Dermatology, and Translational Science at UPMC Hillman Cancer Center. Dr. Kirkwood has expertise all phases of melanoma and has contributed 600 publications and been involved in >300 clinical trials. He has been inducted into the Association of American Physicians and Giants of Cancer Care, and for >20 years America's Top Doctors for Cancer and Pittsburgh Magazine Best Doctors among others.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1977 - 1979
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1973 - 1976
  • Yale School of Medicine
    Yale School of MedicineClass of 1973

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1986 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors for Cancer Castle Connolly, 2005-2019
  • Pittsburgh Magazine Best Doctors Castle Connolly, 2005-2019
  • Distinguished Service Professor of Medicine University of Pittsburgh, 2018

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Prognostic Gene Expression Profiling in Cutaneous Melanoma  
    Douglas Grossman, Sancy A Leachman, Larissa Korde, Elizabeth I Buchbinder, Emily Y Chu, Julia A Curtis, Laura K Ferris, Kenneth F Grossmann, Siwen Hu-Lieskovan, Kari L..., JAMA Dermatology
  • Psychosocial Impact of Skin Biopsies in the Setting of Melanoma Screening – A Cross‐Sectional Survey  
    M A Weinstock, L K Ferris, N H Matthews, J M Kirkwood, F Solano, M Saul, A C Geller, The British Journal of Dermatology

Lectures

  • Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma 
    Imedex, Baltimore, Maryland - 9/13/2013

Authored Content

  • Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020

Press Mentions

  • Immunotherapy After Surgery Shows Promise in Treating Rare, Aggressive Skin Cancer
    Immunotherapy After Surgery Shows Promise in Treating Rare, Aggressive Skin CancerOctober 20th, 2025
  • Dysfunctional B Cells: New Cancer Immunotherapy Target
    Dysfunctional B Cells: New Cancer Immunotherapy TargetFebruary 20th, 2025
  • Scientists Identify a New Cancer Immunotherapy Target: Dysfunctional B Cells
    Scientists Identify a New Cancer Immunotherapy Target: Dysfunctional B CellsFebruary 19th, 2025

Grant Support

  • NCI NCTN-Network Lead Academic Participating Site at UPMC Hillman Cancer CenterUNIVERSITY OF PITTSBURGH AT PITTSBURGH2019–2032
  • Melanoma and Skin Cancer Program SPOREUNIVERSITY OF PITTSBURGH AT PITTSBURGH2021–2026
  • Spore In Skin CancerNational Cancer Institute2008–2011
  • Immunologic &Genetic Determinants Of Outcome &Response To Ifn-A2b TherapyNational Cancer Institute2008–2011
  • Career Development ProgramNational Cancer Institute2008–2011

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: